OR WAIT 15 SECS
Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.
by Jill Wechsler, BioPharm International FDA is examining policy options for incorporating genomic information into the regulatory process while encouraging manufacturers to share pharmacogenomic research.
Related Content: